Inflammation plays a critical role in coronary artery disease. In the present study, Taiwanese research departments, therefore, investigated whether L-carnitine supplementation is able to reduce inflammation in patients with this disease. 23 (out of 47) participants were assigned to a test group that received an L-Carnitine supplement (1000 mg/day) for 12 weeks. The other 24 patients were assigned to a placebo group. After supplementation with L-carnitine, the participants showed significantly reduced levels of the inflammatory markers CRP, IL-6, and TNF-α compared to measurements before supplementation – and compared to the levels in the placebo group. These results indicate that L-carnitine supplementation, due to its antioxidant effects, may be helpful in the treatment of coronary artery disease. Further details can be found in the study.
Lee et al.